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Storage DiseasesDear Sir,
I read with interest the recent and extraordinary article by
Surmeli-Onay et al,1 describing a case of nonimmune
hydrops fetalis (NIHF) due to prenatal onset of Niemann-
Pick Type C Disease (OMIM 257219). NIHF is a severe and
challenging foetal condition usually defined as an exces-
sive fluid accumulation within the foetal extravascular
compartments and body cavities, presenting with gener-
alized skin thickness of >5 mm, placental enlargement,
pericardial or pleural effusion, or ascites. Hydrops fetalis
is not a diagnosis in itself but rather a symptom, and the
end-stage of a wide variety of disorders. The article1 is
important because it describes the association of NIHF and
lysosomal storage disease (LSD) that is often missed during
the diagnostic work-up of NIHF. The exact incidence of
NIHF (thus excluding the cases of Rhesus isoimmunization)
is estimated at 1 case in 2000-3000 pregnancies. The
incidence of inborn errors of metabolism, including LSD, in
the diagnosis of NIHF varies from a minimum of 1% up to
18%, obtained in 13 different studies (references from the
Author on request). The broad differences among these 13
different studies might be explained by the fact that some
of them presented, in my opinion, a sort of bias. These
data were obtained exclusively from published papers,
including single case reports like the article by Surmeli-
Onay et al.1 As already suggested, the incidence of LSD
is probably higher than the reported 1%, but it is most
likely much lower than the unlikely figure of 18%. The
highest reported incidence could be due to a bias linked to
the involvement of specialized centres for metabolic dis-
eases. However, more generally, it has to be underlined
that many cases of NIHF are only partially investigated,1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2013.08.003thus obtaining very low incidences of LSD. Finally, over the
last few years greater attention has been paid to the
relationship between LSD and NIHF; thus, older reviews or
large series studies may have underestimated the true
incidence of LSD. I agree with the author’s conclusions
that identifying index cases is essential. In an effort to
diagnose an ever greater number of NIHF idiopathic
cases, two articles suggested the use of specifically
designed protocols to diagnose NIHF during the prenatal
and neonatal period, and to diagnose LSD in NIHF,
respectively.2,3References
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